Paxil and Other Antidepressants Associated with Birth Defects
The American College of Obstetricians and Gynecologists (ACOG) has recently published an opinion regarding the use of selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors for treatment of depression during pregnancy. ACOG warns that a particular SSRI known as Paxil (generic: paroxetine) should be avoided when possible by pregnant women or women who plan to become pregnant, due to the potential risk of fetal heart defects, newborn persistent pulmonary hypertension, and other negative effects.
Continue reading "Paxil and Other Antidepressants Associated with Birth Defects" »
